What is the maximum dose of propofol (2,6-diisopropylphenol) for induction and maintenance of sedation or anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Propofol

For ICU sedation in adults, propofol maintenance rates should not exceed 70 mcg/kg/min (4.2 mg/kg/h) to avoid propofol infusion syndrome (PRIS), with most patients requiring 5-50 mcg/kg/min (0.3-3 mg/kg/h) for adequate sedation. 1, 2

Critical Safety Threshold

Propofol doses exceeding 4-5 mg/kg/h (approximately 67-83 mcg/kg/min) for prolonged periods (>48 hours) must be avoided due to the risk of fatal propofol infusion syndrome. 2, 3 This syndrome is characterized by:

  • Severe metabolic acidosis
  • Rhabdomyolysis of cardiac and skeletal muscle
  • Cardiac arrhythmias (bradycardia, bundle branch block, asystole)
  • Myocardial failure and circulatory collapse
  • Renal failure and death 2, 3

PRIS has been reported even at lower infusion rates (1.9-2.6 mg/kg/h), indicating that the traditional "safe" threshold may need re-evaluation. 2

Context-Specific Maximum Doses

Induction of Anesthesia

Healthy adults (<55 years, ASA I-II):

  • Standard dose: 2-2.5 mg/kg administered as approximately 40 mg every 10 seconds 4, 5

Elderly, debilitated, or ASA III-IV patients:

  • Reduced dose: 1-1.5 mg/kg administered as approximately 20 mg every 10 seconds 4
  • Rapid bolus administration must be avoided in these populations as it significantly increases risk of hypotension, apnea, airway obstruction, and oxygen desaturation 4

Pediatric patients (3-16 years, ASA I-II):

  • 2.5-3.5 mg/kg, with younger children requiring higher doses than older children 4

Maintenance of Anesthesia

Adults:

  • Continuous infusion: 100-200 mcg/kg/min (6-12 mg/kg/h) with nitrous oxide 4
  • Higher rates (150-200 mcg/kg/min) typically required for first 10-15 minutes, then decrease by 30-50% 4
  • Optimal maintenance rates of 50-100 mcg/kg/min should be targeted to optimize recovery times 4

Pediatric patients:

  • Initial maintenance: 200-300 mcg/kg/min (12-18 mg/kg/h) 4
  • After first 30 minutes: 125-150 mcg/kg/min (7.5-9 mg/kg/h) 4
  • Younger children require higher maintenance rates than older children 4

Monitored Anesthesia Care (MAC) Sedation

Adults:

  • Typical range: 25-75 mcg/kg/min (1.5-4.5 mg/kg/h) 4
  • Initiation: 100-150 mcg/kg/min for 3-5 minutes, then titrate 4
  • Rapid bolus administration is contraindicated for MAC sedation, especially in elderly, debilitated, or ASA III-IV patients 4

Procedural Sedation

Pediatric emergency department procedures:

  • Initial bolus: 1-2 mg/kg 6
  • Supplemental boluses: 0.5-1 mg/kg as needed 6
  • Mean effective doses ranged from 2.9-3.9 mg/kg across multiple studies 6
  • Maximum single bolus documented: 7.5 mg/kg (pentobarbital comparison study) 6

Endoscopic sedation (NAPS protocols):

  • Mean doses for EGD: 107-245 mg total 6
  • Mean doses for colonoscopy: 144-287 mg total 6
  • When targeting moderate sedation: 72 mg (EGD) and 94 mg (colonoscopy) 6

Combination propofol (with opioids/benzodiazepines):

  • Significantly lower doses: 35-70 mg for EGD, 65-100 mg for colonoscopy 6
  • Initial bolus reduced to 10-20 mg when combined with other sedatives 1

Cardiac Anesthesia Considerations

When propofol is the primary agent:

  • Maintenance rates should not be less than 100 mcg/kg/min 4
  • Must be supplemented with analgesic levels of continuous opioid 4

When opioid is the primary agent:

  • Propofol maintenance rates should not be less than 50 mcg/kg/min 4
  • Propofol should NOT be administered with high-dose opioid technique as this increases likelihood of hypotension 4

Pharmacokinetic Rationale for Dosing Limits

Propofol follows a three-compartment model with half-lives of 2-4 minutes, 30-45 minutes, and 3-63 hours. 7 The drug is highly lipophilic with:

  • Rapid distribution into small central compartment (V1)
  • Slower redistribution from larger peripheral compartments (V2 and V3) 8
  • A descending dosing strategy is necessary to maintain constant central compartment concentration while preventing excessive accumulation 8

Target blood concentration for sedation is approximately 1 mg/L, with recovery occurring at concentrations ≤1 mg/L in most patients. 8 Hypnosis is maintained by blood concentrations of 1.5-6 mcg/mL with nitrous oxide supplementation. 7

Common Pitfalls to Avoid

Never administer loading doses in hemodynamically unstable patients - propofol causes dose-dependent decreases in cardiac output, systemic vascular resistance, and arterial pressure. 9, 1

Never use doses >70 mcg/kg/min or prolonged infusions without monitoring for PRIS - monitor for metabolic acidosis, elevated creatine kinase, myoglobinuria, and cardiac arrhythmias. 1, 2

Never forget propofol has no analgesic properties - painful procedures require additional analgesics; propofol alone is insufficient. 1

Never ignore propofol's caloric contribution - the lipid emulsion provides 1.1 kcal/mL, which must be factored into nutritional calculations. 1

Never use rapid bolus technique in elderly or ASA III-IV patients - this dramatically increases risk of cardiovascular collapse and respiratory depression. 4

Monitoring Requirements

Continuous monitoring is mandatory and includes: 6, 9, 1

  • Heart rate
  • Blood pressure
  • Pulse oximetry
  • Supplemental oxygen administration (recommended in most protocols) 6, 1
  • Consider capnography for deeper sedation 6

Approximately 5-10% of patients experience transient oxygen desaturation <90%, typically responding to simple airway maneuvers. 6, 1

References

Guideline

Propofol Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Propofol: therapeutic indications and side-effects.

Current pharmaceutical design, 2004

Research

Pharmacology of propofol.

Annals of the Academy of Medicine, Singapore, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacology of propofol: an intravenous anesthetic agent.

DICP : the annals of pharmacotherapy, 1989

Guideline

Management of Hypertension During Propofol Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.